Edit
Pharmacofore
http://www.pharmacofore.com/Last activity: 29.02.2012
Active - Reference to HugeDomains
Total raised: $10M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 29.12.2011 | - | $10M | Founders F... |
Mentions in press and media 4
| Date | Title | Description |
| 29.02.2012 | Tamper-resistant formulation of pain drugs hopes to reduce narcotic abuse | With the series B funding, Collegium will begin a phase 3 clinical study in patients with lower back pain. CEO Michael Heffernan told VentureWire he plans to file a new drug application (NDA) in 2013. COL-003 and COL-172, a similar formulat... |
| 29.12.2011 | PharmacoFore Raises $10M in Funding from Founders Fund | PharmacoFore, a San Carlos, CA-based biopharmaceutical company, has raised $10m in equity funding from Founders Fund. The company intends to use the new capital to advance its pipeline (read here) to regulatory approval and commercializatio... |
| 19.12.2011 | Zynga, Twitter, NextG: Bay Area BizTech by the Numbers | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Time for our roundup of the latest deals news from Bay Area technology companies, from biggest to smallest. And today’s biggest numbers are pretty big. $1 billion—The approxim... |
| - | Tamper-resistant formulation of pain drugs hopes to reduce narcotic abuse | Making prescription painkillers harder to abuse is the goal of a specialty pharmaceutical company that’s just secured $22.5 million to complete late-stage trials and seek regulatory approval for its tamper-resistant drug technology. Collegi... |